Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) EPS (Basic) : د.إ-0.09 (TTM As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

What is Gulf Pharmaceutical Industries PSC EPS (Basic)?

Gulf Pharmaceutical Industries PSC's basic earnings per share (Basic EPS) for the three months ended in Dec. 2023 was د.إ-0.01. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2023 was د.إ-0.09.

Gulf Pharmaceutical Industries PSC's EPS (Diluted) for the three months ended in Dec. 2023 was د.إ-0.01. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was د.إ-0.09.

Gulf Pharmaceutical Industries PSC's EPS without NRI for the three months ended in Dec. 2023 was د.إ-0.02. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2023 was -0.09.

During the past 3 years, the average EPS without NRI Growth Rate was 26.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was 47.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Gulf Pharmaceutical Industries PSC's highest 3-Year average EPS without NRI Growth Rate was 144.00% per year. The lowest was -19.90% per year. And the median was 26.40% per year.

Gulf Pharmaceutical Industries PSC EPS (Basic) Historical Data

The historical data trend for Gulf Pharmaceutical Industries PSC's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gulf Pharmaceutical Industries PSC EPS (Basic) Chart

Gulf Pharmaceutical Industries PSC Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

Get a 7-Day Free Trial

-0.69

-0.28

0.06

-0.03

-0.09

Gulf Pharmaceutical Industries PSC Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EPS (Basic)	Get a 7-Day Free Trial															-0.03	-	-0.04	-0.03	-0.01

Gulf Pharmaceutical Industries PSC EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Gulf Pharmaceutical Industries PSC's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-99.1	-	0)	/	1155.300
	=	-0.09

Gulf Pharmaceutical Industries PSC's Basic EPS for the quarter that ended in Dec. 2023 is calculated as

Basic EPS (Q: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-15.7	-	0)	/	1155.300
	=	-0.01

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was د.إ-0.09

Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Gulf Pharmaceutical Industries PSC EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Gulf Pharmaceutical Industries PSC's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Airport Road, P.O. Box 997, Digdaga, Ras Al Khaimah, ARE

Website

https://www.julphar.net

Gulf Pharmaceutical Industries PSC is a generic pharmaceutical manufacturer in the Middle East and North Africa. The company manufactures and sells pharmaceuticals and medical compounds, including cosmetics compounds, and drugs. It operates in four segments: Manufacturing, Planet, Investments, and others. It maintains a diverse product portfolio that targets various therapeutic segments including Gastrointestinal Tract (GIT), Respiratory, Pain Management, Wounds & Scars, Anti-infectives, Anemia, Gynecology, Dermatology, Erectile Dysfunction, and Cardiology. The geographical segments are UAE, Other GCC countries, and Other countries.

Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Headlines

No Headlines